Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning Using Behavioral Nudges
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this randomized controlled trial is to evaluate whether behavioral nudges can reduce automation bias, the uncritical acceptance of automated output, in physicians using large language models (LLM) like ChatGPT-5.1 for clinical decision-making. The main question it aims to answer is: Does a dual-mechanism behavioral nudge intervention (baseline accuracy anchoring plus case-specific color-coded confidence signals) reduce physicians' uncritical acceptance of incorrect LLM recommendations? Researchers will compare physicians who receive LLM recommendations along with a behavioral nudge to those who receive LLM recommendations without the nudge to assess if the nudge reduces automation bias. Participants will:
- Evaluate six clinical vignettes accompanied by LLM-generated recommendations (half containing deliberate, clinically significant errors).
- Control group: Be able to view LLM recommendations in standard format without the nudge.
- Treatment group: Be able to view ChatGPT's diagnostic accuracy on standard medical datasets as an initial anchor, then receive color-coded confidence signals alongside each recommendation (e.g., red for low confidence).
- Have their responses evaluated by blinded reviewers using an expert-developed assessment rubric to detect uncritical acceptance of erroneous information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedStudy Start
First participant enrolled
January 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
March 31, 2026
March 1, 2026
6 months
December 26, 2025
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic reasoning accuracy score
The primary outcome will be the percent correct for each case, ranging from 0 to 100%, where higher scores indicate better diagnostic performance. For each case, participants will be asked for their three leading diagnoses, findings that support each diagnosis, and findings that oppose each diagnosis. For each plausible diagnosis, participants will receive 1 point. Findings supporting the diagnosis and findings opposing the diagnosis will also be graded based on correctness, with 1 point for each correct response. Participants will then be asked to name their top diagnosis they believe is most likely, earning 9 points for a reasonable response and 18 points for the most accurate response. Finally participants will be asked to name up to 3 next steps to further evaluate the patient with 0.5 point awarded for a partially correct response and 1 point for a completely correct response. The primary outcome will be compared at the case-level between the randomized groups.
Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.
Secondary Outcomes (1)
Top choice diagnosis accuracy score
Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.
Study Arms (2)
ChatGPT Recommendations alongside a Behavioral Nudge
ACTIVE COMPARATORParticipants will evaluate six clinical vignettes. During the trial, they will have access to clinical recommendations from a specific, commercially available LLM (ChatGPT) in addition to conventional diagnostic resources. LLM recommendations for three vignettes will contain deliberately flawed diagnostic information and for three vignettes it will contain accurate recommendations). The cases will be presented in random order. Participants in this arm will receive a behavioral nudge embedded in the LLM recommendations interface that presents two synchronized cognitive cues when the LLM panel is expanded: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the panel to set realistic expectations before cue intervention located immediately below, which shows the LLM recommendations alongside a case-specific color-coded confidence signal.
ChatGPT Recommendations without a Behavioral Nudge
NO INTERVENTIONParticipants will evaluate six clinical vignettes. During the trial, they will have access to clinical recommendations from a specific, commercially available LLM (ChatGPT) in addition to conventional diagnostic resources. LLM recommendations for three vignettes will contain deliberately flawed diagnostic information. The cases will be presented in random order. Participants in this arm will not receive any behavioral nudge.
Interventions
Participants in the treatment group will receive a behavioral nudge intervention embedded in the LLM recommendations interface that presents two synchronized cognitive cues when the LLM panel is expanded: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the panel to set realistic expectations before viewing the specific recommendation, and (2) a selective attention cue located immediately below, which shows the LLM recommendation alongside a case-specific and color-coded confidence signal. This signal is categorized as red when the mean ensemble confidence falls below the established baseline accuracy, flagging high-uncertainty cases that demand critical evaluation; orange when confidence meets or exceeds the baseline but remains below 100%, intended to prevent complacency and maintain active clinical scrutiny; and green for a 100% ensemble consensus, though standard cautionary warnings still apply to guard against.
Eligibility Criteria
You may qualify if:
- Full or Provisionally Registered Medical Practitioners with the Pakistan Medical and Dental Council (PMDC).
- Completed Bachelor of Medicine, Bachelor of Surgery (MBBS) Exam. The equivalent degree of MBBS in US and Canada is the Doctor of Medicine (MD).
- Participants must have completed a structured training program on the use of ChatGPT (or a comparable large language model), totaling at least 10 hours of instruction. The program must include hands-on practice related to LLM's key aspects, specifically prompt engineering and content evaluation.
You may not qualify if:
- Any other Registered Medical Practitioners (Full or Provisional) with PMDC (e.g., professionals with Bachelor of Dental Surgery or BDS).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lahore University of Management Sciences
Lahore, Punjab Province, 54792, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ihsan Ayyub Qazi, PhD
Lahore University of Management Sciences (LUMS)
- PRINCIPAL INVESTIGATOR
Muhammad Hamad Alizai, PhD
Lahore University of Management Sciences (LUMS)
- PRINCIPAL INVESTIGATOR
Muhammad Asadullah Khawaja, MBBS
King Edward Medical University
- PRINCIPAL INVESTIGATOR
Ali Zafar Sheikh, MBBS
Lahore General Hospital
- PRINCIPAL INVESTIGATOR
Muhammad Junaid Akhtar, MBBS
Children's Hospital, Lahore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single (Outcomes Assessor)
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor, PhD
Study Record Dates
First Submitted
December 26, 2025
First Posted
January 9, 2026
Study Start
January 17, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
March 31, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share